Inteliquet
  • For Life Sciences
  • For Healthcare
    • For Healthcare Organizations
    • OncWeb™ Clinical Trial Software Platform
  • Cancer Center Research Consoritum
  • About Us
    • About Us
    • Leadership
  • News & Insights
    • News
    • Blog
    • Resources
  • Contact
  • REQUEST A DEMO
Select Page
Dave Hadley, PhD, Chosen For The 2020 Class Of “40 Under 40 in Cancer”

Dave Hadley, PhD, Chosen For The 2020 Class Of “40 Under 40 in Cancer”

by Inteliquet | Oct 30, 2020 | healthcare, Oncology, Uncategorized

Recently Inteliquet’s David Hadley, PhD, our Director of Data Science, was recognized as a member of the 2020 class of “40 Under 40 in Cancer.” David’s extensive experience in clinical research and clinical decision support has made him well-adept at parsing out...
Outsourcing Pharma – Inteliquet: COVID-19 transforming oncology trial landscape

Outsourcing Pharma – Inteliquet: COVID-19 transforming oncology trial landscape

by Inteliquet | Oct 30, 2020 | Clinical Trials, News & Resources, Oncology, patients

By Jenni Spinner  A leader from the cancer patient matching and analysis solutions firm discusses how and other forces are pushing innovation in the oncology research space. (Nicola Ferrari/iStock via Getty Images Plus) Outsourcing-Pharma (OSP) talked with Marie...
ASCO 2020: “Real-world Hypothesis-generating Cohort of Pancreatic Cancer Patients with Brain Metastases”

ASCO 2020: “Real-world Hypothesis-generating Cohort of Pancreatic Cancer Patients with Brain Metastases”

by David Hadley, PhD | Jun 1, 2020 | ASCO, clinical data, clinical research, NSCLC, Oncology, patients, Uncategorized

At this year’s ASCO 2020, we presented the following abstract that examines a first step to better understand the relationship between pancreatic cancer (PC) and brain metastases.  Along with being the largest study of PC patients with brain...
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress